Migraine, the impact of menopause
Migraines affect 1 in 5 women, with three times as many women being affected as men. The symptoms can be really debilitating and include much more than headaches. Triggers There is often a history of migraine in the family, suggesting a genetic susce…
Read MoreFezolinetant (Veoza®), what you need to know about the new non-hormonal treatment for hot flushes.
The new non-hormonal drug for hot flushes and night sweats, Fezolinetant, is part of an entirely new class of drug, the NK3 antagonists. Fezolinetant has now been approved for use in the UK, having been approved for use in the USA since May 2023. Cur…
Read More